David Alan Campbell
Bayer
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David Alan Campbell.
Current Opinion in Chemical Biology | 2003
David Alan Campbell; Anna Katrin Szardenings
The analysis of proteomic samples with affinity labels has been firmly established as a tool for the post-genomic researcher. Recent examples highlight the advantages of profiling functionally active members of specific protein families to identify therapeutically relevant protein targets that have escaped normal physiological regulation leading to increased or decreased activity. This dysregulation may result from any number of biological changes that modulate a proteins activity; for example, post-translational modifications of the protein or an imbalance between the protein and its endogenous inhibitor(s). By providing a direct measure of a proteins functional activity, affinity probe analysis identifies these changes and allows investigators to focus their research efforts upon those proteins that are most likely to be responsible for the biological changes under evaluation.
Bioorganic & Medicinal Chemistry Letters | 2009
Amogh Boloor; Denise Hanway; Maria Joshi; David T. Winn; Gabriel Mendez; Marlena Walls; Ping Wei; Fuxin Qian; Xiaoli Zhang; Yuliang Zhang; Michael Hepperle; Xinqiang Li; David Alan Campbell; Juan Manuel Betancort
A new series of NS3/4A protease boronic acid inhibitors is described. The compounds show good biochemical potency and cellular activity. The peptidomimetic inhibitors were evaluated against proteases from different HCV genotypes and clinically relevant NS3/4A mutants. Compound 28 displayed subnanomolar to single digit nanomolar potencies in the enzymatic assays and an EC50 of 25 nM in the replicon cell-based assay.
Bioorganic & Medicinal Chemistry Letters | 1998
David Alan Campbell; Xiao-Yi Xiao; David Harris; Satoru Ida; Reza Mortezaei; Khehyong Ngu; Lihong Shi; David Tien; Yongwen Wang; Marc Navre; Dinesh V. Patel; Michele A. Sharr; John F. DiJoseph; Loran M. Killar; Christina Louise Leone; Jeremy I. Levin; Jerauld S. Skotnicki
Abstract A novel series of matrix metalloproteinase (MMP) inhibitors is described. Incorporation of a terminal α-mercaptoketone or α-mercaptoalcohol in the zinc binding domain of a series of inhibitors led to compounds exhibiting low nanomolar activity against collagenase-1 (MMP-1), stromelysin (MMP-3), and gelatinase-B (MMP-9).
Bioorganic & Medicinal Chemistry Letters | 2009
Juan Manuel Betancort; David T. Winn; Ruzhang Liu; Quansheng Xu; Junjuan Liu; Wensheng Liao; Shuhui Chen; David Carney; Denise Hanway; James Schmeits; Xinqiang Li; Eric M. Gordon; David Alan Campbell
The synthesis and biochemical evaluation of novel cyanothiazolidine inhibitors of dipeptidyl peptidase 4 (DPP4) is described. Their main structural feature is a constrained bicyclic core that prevents the intramolecular formation of inactive cyclic species. The inhibitors show good to moderate biochemical potency against DPP4 and display distinct selectivity profiles towards DPP7, DPP8 and DPP9 depending on their substitution.
Molecular Diversity | 1998
Reza Mortezaei; Satoru Ida; David Alan Campbell
A general method was developed to generate six-membered cyclic thiazinanes on solid support. Three diversity sites were introduced into this scaffold using primary amines, aldehydes, and 2-bromoalkanoic acids. The methodology to prepare individual cyclic thiazinanes as well as combinatorial libraries of these compounds is described.
Archive | 2004
David Alan Campbell; David T. Winn; Juan Manuel Betancort
Archive | 1996
Anna Katrin Szardenings; David Alan Campbell
Journal of Medicinal Chemistry | 1999
Anna Katrin Szardenings; Valery V. Antonenko; David Alan Campbell; Nuria DeFrancisco; Satoru Ida; Lihong Shi; Nikolai Sharkov; David Tien; Yongwen Wang; Marc Navre
Antimicrobial Agents and Chemotherapy | 1998
Joy L. Silen; Amy T. Lu; Dennis W. Solas; Medini A. Gore; Derek Maclean; Nikil H. Shah; Jill M. Coffin; Naseema S. Bhinderwala; Yongwen Wang; Ken Tsutsui; Gary C. Look; David Alan Campbell; Ron L. Hale; Marc Navre; Camille R. DeLuca-Flaherty
Journal of Medicinal Chemistry | 1998
Anna Katrin Szardenings; David Harris; Stuart Lam; Lihong Shi; David Tien; Yongwen Wang; Dinesh V. Patel; Marc Navre; David Alan Campbell